查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
兽用静脉注射市场规模、份额和趋势分析报告：按产品、动物类型、适应症、最终用途、地区、细分市场预测，2023-2030年
市场调查报告书
商品编码
1321420

兽用静脉注射市场规模、份额和趋势分析报告：按产品、动物类型、适应症、最终用途、地区、细分市场预测，2023-2030年

Veterinary Intravenous (IV) Solutions Market Size, Share & Trends Analysis Report By Product, By Animal Type (Companion Animals, Production Animals), By Indication, By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

兽用静脉注射市场的成长与趋势

Grand View Research, Inc.最新报告显示，预计2030年全球兽用静脉注射市场规模将达26.7亿美元，2023年至2030年年复合成长率为8.37%。

这一增长的推动因素包括动物福利意识的提高、兽医学的进步、宠物饲养量的增加以及炭疽、胰臟炎和口腔炎等疾病盛行率的增加。兽医学的进步扩大了动物的治疗选择。兽医医院和诊所配备了IV系统等先进的诊断和治疗设备，有助于市场的成长。

专为兽医设计的先进输液系统的开发使给药过程更加高效、准确和安全。这些技术进步，例如专用输液帮浦和输液监测系统，透过加强患者照护和降低併发症风险，对兽医静脉注射产业产生积极影响。许多地区可支配收入水准的上升正在增加宠物医疗保健的支出。宠物饲主越来越愿意投资于优质兽医护理，包括输液治疗，从而促进市场成长。

随着全球形势的不断发展，COVID-19 后对兽用静脉注射产业的影响仍有待确定。 COVID-19 大流行的恢復增加了对静脉注射兽用液体的需求，作为在手术、治疗和严重情况下为动物提供护理标准的一部分。大流行的经济影响影响了许多个人和企业，包括宠物饲主和兽医医院。财务限制可能会影响宠物饲主的决策流程，并可能导致非必要的兽医程序和治疗的减少，包括静脉输液的使用。

此外，由于多种要素，包括北美兽医教育计画强调液体治疗的重要性及其在各种临床情况下的适当使用，北美静脉注射兽医液体的采用率相对较高。兽医和兽医技术人员接受静脉输液管理、监测和管理的广泛培训，并练习正确使用静脉输液。此外，北美兽医专业人士努力为动物提供优质护理。输液治疗是综合兽医治疗的重要组成部分，其采用是基于优化患者照护和支持动物康復和健康的承诺。

兽用静脉注射市场报告亮点

  • 从产品来看，等渗结晶器细分市场占据主导地位，到 2022 年，其份额将超过 42%。等渗透压晶体经常用于兽医液体治疗中，以供给和维持动物的水合和电解质平衡。
  • 按动物类型划分，伴侣动物细分在 2022 年占据市场主导地位。许多家庭经常饲养伴侣动物，尤其是狗和猫作为宠物。养宠物导致对静脉注射静脉注射的大量需求。这是因为这些动物经常需要静脉注射治疗来解决各种健康问题、手术或严重的治疗情况。
  • 有迹象表明，糖尿病酮酸症(DKA) 细分市场将在 2022 年占据主导地位。
  • 从最终用途来看，随着越来越多的人将宠物带到兽医诊所，兽医院细分市场将在 2022 年占据市场主导地位，收入份额将超过 55%。静脉供给疗法在兽医院中经常使用，作为患者照护的重要组成部分。
  • 2022年，北美地区的销售份额最高，超过38.0%的市占率。在北美，宠物拥有率很高，许多家庭饲养狗、猫和小型哺乳动物等伴侣动物。

目录

第1章调查方法和范围

  • 市场区隔和范围
  • 调查方法
  • 资讯采购
  • 资讯或资料分析
  • 市场形成与检验
  • 型号详情
  • 资料来源列表

第2章执行摘要

第3章兽用静脉注射市场变数、趋势和范围

  • 市场体系预测
    • 母市场预测
    • 附随市场预测
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
    • 市场机会分析
    • 市场问题分析
  • 兽用静脉注射市场分析工具
    • 产业分析-波特
    • PESTEL分析
    • 价格分析
    • 2018-2022 年主要国家估计动物数量
    • COVID-19感染疾病的影响分析

第4章兽用静脉注射市场：产品评估及趋势分析

  • 细分仪表板
  • 兽用静脉注射市场：2022 年和 2030 年产品变化分析和市场份额
  • 等渗晶体液体
  • 合成胶体
  • 血液製品
  • 葡萄糖溶液
  • 肠外营养

第5章兽用静脉注射市场：适应症估计和估计/趋势分析

  • 细分仪表板
  • 兽用静脉注射市场：2022 年和 2030 年适应症变化分析和市场份额
  • 糖尿病酮酸症
  • 胰臟炎
  • 炭疽菌
  • 慢性肾臟病
  • 其他的

第6章兽用静脉注射市场：动物类型估算及趋势分析

  • 细分仪表板
  • 兽用静脉注射市场：2022 年和 2030 年动物类型变异分析和市场份额
  • 伴侣动物
  • 生产动物

第7章兽用静脉注射市场：最终用途估计和趋势分析

  • 细分仪表板
  • 兽用静脉注射市场：2022 年和 2030 年最终用途变化分析和市场份额
  • 动物医院
  • 研究机构
  • 其他的

第8章兽用静脉注射市场：区域估计及趋势分析

  • 区域展望
  • 兽用静脉注射市场：2022 年和 2030 年区域变化分析和市场份额
  • 北美洲
    • SWOT分析
    • 2018年至2030年北美兽用静脉静脉注射市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • SWOT分析
    • 2018-2030 年欧洲兽用静脉静脉注射市场估计与预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • SWOT分析
    • 2018-2030年亚太地区兽用静脉静脉注射市场估计与预测
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • SWOT分析
    • 2018-2030 年拉丁美洲兽用静脉注射市场估计与预测
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • SWOT分析
    • 2018年至2030年中东和非洲兽用静脉注射输液市场估计和预测
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第9章竞争形势

  • 主要公司简介
    • Participant's Overview
    • Product Benchmarking
    • Financial Performance
    • Strategic Initiatives
  • 参与企业
  • 热图分析/公司市场分析
  • 策略规划
  • 其他主要市场参与者名单
Product Code: GVR-4-68040-099-7

Veterinary Intravenous Solutions Market Growth & Trends

The global veterinary intravenous solutions market size is expected to reach USD 2.67 billion by 2030, expanding at a CAGR of 8.37% from 2023 to 2030, according to a new report by Grand View Research, Inc. The growth is driven by increasing awareness of animal welfare, advancements in veterinary healthcare, increasing pet ownership, and the increasing prevalence of illnesses such as anthrax, pancreatitis, and mouth disease. The advancements in veterinary medicine have expanded the range of treatment options available for animals. Veterinary clinics and hospitals are equipped with advanced diagnostic and treatment facilities, including intravenous fluid administration systems, which contribute to the growth of the market.

The development of advanced IV fluid delivery systems designed specifically for veterinary use has made the administration process more efficient, accurate, and safe. These technological advancements, such as specialized infusion pumps and fluid monitoring systems, have positively impacted the veterinary intravenous solutions industry by enhancing patient care and reducing the risk of complications. Rising disposable income levels in many regions have led to increased spending on pet healthcare. Pet owners are more willing to invest in high-quality veterinary care, including intravenous fluid therapy, which contributes to the growth of the market.

The post-COVID-19 impact on the veterinary intravenous solutions industry is still unfolding as the global situation continues to evolve. The COVID-19 pandemic recovery has led to an increased demand for veterinary intravenous solutions as part of the standard care provided to animals during surgeries, treatments, and critical care situations. The economic impact of the pandemic affected many individuals and businesses, including pet owners and veterinary clinics. Financial constraints may have influenced the decision-making process for pet owners, potentially leading to a decrease in non-essential veterinary procedures and treatments, including the use of IV fluids.

Moreover, the adoption of veterinary intravenous (IV) fluid solutions in North America is relatively high due to various factors such as veterinary education programs in North America emphasizing the importance of IV fluid therapy and its appropriate use in different clinical situations. Veterinarians and veterinary technicians receive extensive training in the administration, monitoring, and management of IV fluids, ensuring their competent use in practice. Furthermore, veterinary professionals in North America strive to provide high-quality care for animals. IV fluid therapy is a crucial component of comprehensive veterinary treatment, and its adoption is driven by the commitment to optimize patient care and support the recovery and well-being of animals.

Veterinary Intravenous Solutions Market Report Highlights

  • Based on product, the isotonic crystalloids segment dominated the market with a share of over 42% in 2022. To restore and maintain hydration and electrolyte balance in animals, fluid therapy in veterinary medicine frequently uses isotonic crystalloid solutions
  • Based on animal type, the companion animals segment dominated the market in 2022. Many homes regularly keep companion animals as pets, especially dogs and cats. Pet ownership leads to a large demand for veterinary intravenous solutions, as these animals frequently require intravenous therapy for a variety of health issues, surgeries, or critical care situations
  • Based on indication, the Diabetic Ketoacidosis (DKA) segment dominated the market in 2022
  • Based on end-use, the veterinary hospital segment dominated the market with a revenue share of over 55% in 2022, as more people are taking their pets to veterinarian facilities for care. IV hydration therapy is frequently used in veterinary hospitals as a crucial part of patient care
  • North America held the highest revenue share of over 38.0% of the market in 2022. In North America, there is a high rate of pet ownership, with many homes keeping companion animals like dogs, cats, and small mammals

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Veterinary Intravenous Solutions Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing demand for companion animals and pets
      • 3.2.1.2. Increasing prevalence of illnesses such as anthrax, pancreatitis, mouth disease
      • 3.2.1.3. Increase in the need for nutrition-rich food, focus on food safety, and increasing care for animals
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Lack of awareness regarding the use of veterinary intravenous solutions
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Veterinary Intravenous Solutions Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape
    • 3.3.3. Pricing Analysis
    • 3.3.4. Estimated Animal Population, by key countries, 2018 to 2022
    • 3.3.5. COVID-19 Impact Analysis

Chapter 4. Veterinary Intravenous Solutions Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Veterinary Intravenous Solutions Market: Product Movement Analysis & Market Share, 2022 & 2030
  • 4.3. Isotonic crystalloids
    • 4.3.1. Isotonic Crystalloids Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Synthetic colloids
    • 4.4.1. Synthetic Colloids Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Blood products
    • 4.5.1. Blood Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Dextrose solutions
    • 4.6.1. Dextrose Solutions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Parenteral nutrition
    • 4.7.1. Parenteral Nutrition Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Veterinary Intravenous Solutions Market: Indication Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Veterinary Intravenous Solutions Market: Indication Movement Analysis & Market Share, 2022 & 2030
  • 5.3. Diabetic Ketoacidosis
    • 5.3.1. Diabetic Ketoacidosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Pancreatitis
    • 5.4.1. Pancreatitis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Anthrax
    • 5.5.1. Anthrax Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Chronic Kidney Disease
    • 5.6.1. Chronic Kidney Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Veterinary Intravenous Solutions Market: Animal Type Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Veterinary Intravenous Solutions Market: Animal Type Movement Analysis & Market Share, 2022 & 2030
  • 6.3. Companion Animals
    • 6.3.1. Companion Animals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Production Animals
    • 6.4.1. Production Animals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Veterinary Intravenous Solutions Market: End-use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Veterinary Intravenous Solutions Market: End-Use Movement Analysis & Market Share, 2022 & 2030
  • 7.3. Veterinary Hospitals
    • 7.3.1. Veterinary Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Research Institutes
    • 7.4.1. Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Others
    • 7.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Veterinary Intravenous Solutions Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Outlook
  • 8.2. Veterinary Intravenous Solutions Market: Regional Movement Analysis & Market Share, 2022 & 2030
  • 8.3. North America
    • 8.3.1. SWOT Analysis
    • 8.3.2. North America Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. The U.S.
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Regulatory Framework
      • 8.3.3.3. U.S. Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. Canada
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Regulatory Framework
      • 8.3.4.3. Canada Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. SWOT Analysis
    • 8.4.2. Europe Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. UK
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Regulatory Framework
      • 8.4.3.3. UK Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. Germany
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Regulatory Framework
      • 8.4.4.3. Germany Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. France
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Regulatory Framework
      • 8.4.5.3. France Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. Italy
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Regulatory Framework
      • 8.4.6.3. Italy Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Spain
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Regulatory Framework
      • 8.4.7.3. Spain Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Regulatory Framework
      • 8.4.8.3. Denmark Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.9. Sweden
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Regulatory Framework
      • 8.4.9.3. Sweden Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.10. Norway
      • 8.4.10.1. Key Country Dynamics
      • 8.4.10.2. Regulatory Framework
      • 8.4.10.3. Norway Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. SWOT Analysis
    • 8.5.2. Asia Pacific Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Japan
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Regulatory Framework
      • 8.5.3.3. Japan Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. China
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Regulatory Framework
      • 8.5.4.3. China Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. India
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Regulatory Framework
      • 8.5.5.3. India Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. South Korea
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Regulatory Framework
      • 8.5.6.3. South Korea Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Australia
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Regulatory Framework
      • 8.5.7.3. Australia Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.8. Thailand
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Regulatory Framework
      • 8.5.8.3. Thailand Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. SWOT Analysis
    • 8.6.2. Latin America Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Brazil
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Regulatory Framework
      • 8.6.3.3. Brazil Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. Mexico
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Regulatory Framework
      • 8.6.4.3. Mexico Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Argentina
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Regulatory Framework
      • 8.6.5.3. Argentina Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Middle East & Africa
    • 8.7.1. SWOT Analysis
    • 8.7.2. Middle East & Africa Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. South Africa
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Regulatory Framework
      • 8.7.3.3. South Africa Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.7.4. Saudi Arabia
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Regulatory Framework
      • 8.7.4.3. Saudi Arabia Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.7.5. UAE
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Regulatory Framework
      • 8.7.5.3. UAE Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.7.6. Kuwait
      • 8.7.6.1. Key Country Dynamics
      • 8.7.6.2. Regulatory Framework
      • 8.7.6.3. Kuwait Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Key Company Profiles
    • 9.1.1. Participant's Overview
    • 9.1.2. Product Benchmarking
    • 9.1.3. Financial Performance
    • 9.1.4. Strategic Initiatives
      • 9.1.4.1. Merck & Co., Inc.
      • 9.1.4.2. Dechra Veterinary Products
      • 9.1.4.3. Sypharma
      • 9.1.4.4. Animalcare
      • 9.1.4.5. B. Braun SE
      • 9.1.4.6. Woods Consulting, LLC
      • 9.1.4.7. Baxter
      • 9.1.4.8. Fresenius Kabi
  • 9.2. Participant Categorization
  • 9.3. Heat Map Analysis/ Company Market Position Analysis
  • 9.4. Strategy Mapping
  • 9.5. List of Other Key Market Players

List of Tables

  • Table 1 List of secondary sources
  • Table 2 Global Veterinary Intravenous Solutions market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 5 Global Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 6 Global Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 North America Veterinary Intravenous Solutions market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 9 North America Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 10 North America Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 11 North America Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 U.S. Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 13 U.S. Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 14 U.S. Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 15 U.S. Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Canada Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 17 Canada Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 18 Canada Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 19 Canada Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Europe Veterinary Intravenous Solutions market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 22 Europe Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 23 Europe Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 24 Europe Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 UK Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 26 UK Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 27 UK Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 28 UK Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Germany Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 30 Germany Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 31 Germany Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 32 Germany Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 France Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 34 France Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 35 France Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 36 France Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Italy Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 38 Italy Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 39 Italy Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 40 Italy Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Spain Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 42 Spain Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 43 Spain Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 44 Spain Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Denmark Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 46 Denmark Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 47 Denmark Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 48 Denmark Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Sweden Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 50 Sweden Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 51 Sweden Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 52 Sweden Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Norway Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 54 Norway Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 55 Norway Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 56 Norway Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific Veterinary Intravenous Solutions market, by country, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Japan Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 63 Japan Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 64 Japan Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 65 Japan Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 China Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 67 China Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 68 China Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 69 China Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 70 India Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 71 India Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 72 India Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 73 India Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 74 South Korea Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 75 South Korea Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 76 South Korea Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 77 South Korea Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 78 Australia Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 79 Australia Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 80 Australia Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 81 Australia Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 Thailand Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 83 Thailand Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 84 Thailand Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 85 Thailand Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 Latin America Veterinary Intravenous Solutions market, by country, 2018 - 2030 (USD Million)
  • Table 87 Latin America Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 88 Latin America Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 89 Latin America Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 90 Latin America Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 91 Brazil Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 92 Brazil Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 93 Brazil Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 94 Brazil Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 95 Mexico Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 96 Mexico Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 97 Mexico Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 98 Mexico Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 99 Argentina Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 100 Argentina Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 101 Argentina Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 102 Argentina Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 103 MEA Veterinary Intravenous Solutions market, by country, 2018 - 2030 (USD Million)
  • Table 104 MEA Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 105 MEA Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 106 MEA Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 107 MEA Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 108 South Africa Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 109 South Africa Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 110 South Africa Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 111 South Africa Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 116 UAE Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 117 UAE Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 118 UAE Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 119 UAE Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 120 Kuwait Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 124 Participant's overview
  • Table 125 Financial performance
  • Table 126 Product benchmarking
  • Table 127 Strategic Initiative

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Commodity Flow Analysis
  • Fig. 9 Veterinary Intravenous Solutions market revenue, 2018 - 2030 (USD Million)
  • Fig. 10 Veterinary Intravenous Solutions market snapshot
  • Fig. 11 Veterinary Intravenous Solutions market driver impact
  • Fig. 12 Veterinary Intravenous Solutions market restraint impact
  • Fig. 13 Porter's 5 Forces Analysis
  • Fig. 14 PESTEL Analysis
  • Fig. 15 Veterinary Intravenous Solutions market product key takeaways (USD Million)
  • Fig. 16 Veterinary Intravenous Solutions market: product movement analysis
  • Fig. 17 Global Isotonic crystalloids market, 2018 - 2030 (USD Million)
  • Fig. 18 Global Synthetic colloids market, 2018 - 2030 (USD Million)
  • Fig. 19 Global Blood products market, 2018 - 2030 (USD Million)
  • Fig. 20 Global Dextrose solutions market, 2018 - 2030 (USD Million)
  • Fig. 21 Global Parenteral nutrition market, 2018 - 2030 (USD Million)
  • Fig. 22 Veterinary Intravenous Solutions indication key takeaways (USD Million)
  • Fig. 23 Veterinary Intravenous Solutions market: Indication movement analysis
  • Fig. 24 Global Diabetic Ketoacidosis market, 2018 - 2030 (USD Million)
  • Fig. 25 Global Pancreatitis Market, 2018 - 2030 (USD Million)
  • Fig. 26 Global Anthrax market, 2018 - 2030 (USD Million)
  • Fig. 27 Global Chronic Kidney Disease Market, 2018 - 2030 (USD Million)
  • Fig. 28 Global Others market, 2018 - 2030 (USD Million)
  • Fig. 29 Veterinary Intravenous Solutions market animal type key takeaways (USD Million)
  • Fig. 30 Veterinary Intravenous Solutions market: Animal type movement analysis
  • Fig. 31 Global companion animals market, 2018 - 2030 (USD Million)
  • Fig. 32 Global production animals market, 2018 - 2030 (USD Million)
  • Fig. 33 Veterinary Intravenous Solutions market end-use key takeaways (USD Million)
  • Fig. 34 Veterinary Intravenous Solutions market: end-use movement analysis
  • Fig. 35 Global veterinary hospitals market, 2018 - 2030 (USD Million)
  • Fig. 36 Global research institutes market, 2018 - 2030 (USD Million)
  • Fig. 37 Global Others market, 2018 - 2030 (USD Million)
  • Fig. 38 Regional marketplace: Key takeaways
  • Fig. 39 Regional outlook, 2022 & 2030
  • Fig. 40 North America Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 41 U.S. Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 42 Canada Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 43 Europe Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 44 UK Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 45 Germany Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 46 France Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 47 Italy Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 48 Spain Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 49 Denmark Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 50 Sweden Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 51 Norway Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 53 Japan Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 54 China Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 55 India Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 56 South Korea Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 57 Australia Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 58 Thailand Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 59 Latin America Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 60 Brazil Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 61 Mexico Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 62 Argentina Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 63 MEA Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 64 South Africa Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 65 Saudi Arabia Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 66 UAE Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 67 Kuwait Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 68 Market participant categorization
  • Fig. 69 Heat map analysis/Company market position analysis